Loading...
Biobrick
T7
Promoter
RBS
6x His
EK site
CBD
Linker
Thrombin releasable DPK
T7
terminator
T7
Promoter
RBS
6x His
EK site
CBD
Linker
Thrombin releasable D2A
T7
terminator
T7
Promoter
RBS
6x His
EK site
CBD
Linker
Thrombin-TAT
CTSS-DPK
T7
terminator
T7
Promoter
RBS
6x His
EK site
CBD
Linker
Thrombin/DPK mimic
eGFP
T7
terminator
T7
Promoter
RBS
6x His
EK site
CBD
Linker
Thrombin/D2A mimic
eGFP
T7
terminator
T7
Promoter
RBS
6x His
EK site
CBD
Linker
Thrombin/TAT mimic
eGFP
T7
terminator
T7
promoter
RBS
6x His
CBD
Linker
Thrombin releasable TAT47-57
eGFP
T7
terminator
T7
promoter
RBS
6x His
CBD
Linker
Thrombin releasable TAT48-57
eGFP
T7
terminator
T7
promoter
RBS
Thrombin
eGFP
T7
terminator
T7
promoter
RBS
Thrombin
TAT 48-57
eGFP
T7
terminator
T7 promoter
T7 DNA polymerase would recognize DNA sequence of this region and start to transcript.
RBS
Ribosome binding site
Ribosome would recognize the RNA sequence of this region and start to translate.
Thrombin cleavage site
We design LVPR links TAT47-57 and 48-57 to test the release ability.
6xHis
6xHistidine
The hexa hisitidine-tag for protein purification or recognization.
CBD
Collagen binding domain
CBD is coloned from FN1 genes and is able to bind to collagen.
AMP
Antimicrobial peptides
Short cationic peptides that exhibit antimicrobial activity.
T7 terminator
T7 DNA polymerase would recognize the DNA sequence of this region and stop the transcript.
LVPRGK/LVPRFA/
LVPRGR
The modified thrombin cleavage site. The amino acids at P1 and P2' positions of thrombin cleavage site are modified to fit the first two amino acids at N-terminal of selected AMPs or TAT48-57
eGFP
enhanced green fluorescent protein
The enhanced green fluorescent protein
Linker
Linker provides the space to allow thrombin docking and cleavage.
EK site
Enterokinase
cleavage site
Enterokinase can recognize the amino acid sequence of this region to purify our target protein.
Thrombin cleavage site
Thrombin cleavage site can be recognized and cut by thrombins in the wounds in order to release AMP. Moreover, in a normal Thrombin site, the sequence is LVPRGS. After the enzyme reaction, Glycine and Serine will be remained, which have the possibility of affecting AMP’s function. To prevent it from happening, we altered the sequence to LVPR. After a few experiments, it was proof that the alteration won’t affect the function of thrombin.
Thrombin releasable DPK-060
The amino acids at the P1’ and P2’ sites of Thrombin cleavage sites were replaced by G and K to fit the first two amino acids at the N-terminal of DPK-060.
Thrombin releasable D2A21
The amino acids at the P1’ and P2’ sites of Thrombin cleavage sites were replaced by F and A to fit the first two amino acids at the N-terminal of D2A21.
Thrombin releasable TAT48-57
The amino acids at the P1’ and P2’ sites of Thrombin cleavage sites were replaced by G and R to fit the first two amino acids at the N-terminal of TAT48-57. TAT48-57 is small peptides that can carry cargoes into macrophages.
Thrombin DPKmimic
The modified thrombin cleavage site LVPRGK was linked at the N-terminal of eGFP.
Thrombin D2Amimic
The modified thrombin cleavage site LVPRFA was linked at the N-terminal of eGFP.
Thrombin TATmimic
The modified thrombin cleavage site LVPRGR was linked at the N-terminal of eGFP.
Thrombin releasable TAT47-57
The amino acids at the P1’ and P2’ sites of Thrombin cleavage sites were replaced by Y and G to fit the first two amino acids at the N-terminal of TAT47-57.
Thrombin releasable TAT48-57
The amino acids at the P1’ and P2’ sites of Thrombin cleavage sites were replaced by G and R to fit the first two amino acids at the N-terminal of TAT48-57.
Cathepsin S site
Cathepsin S cleavage site can be recognized and cleaved by the lysosomal endopeptidase CTSS.
CTSS releasable DPK060
CTSS cleavage site can be recognized and cleaved by Cathepsin S in phagolysosomes. The amino acids at the P1’ and P2’ sites of CTSS stie cleavage site were replaced by G and K to fit the two amino acids at the N-terminal of DPK060.
TAT48-57
TAT48-57 is small peptides that can carry cargoes into macrophages.
Basic part
Part name | Description | Length(bp) |
---|---|---|
BBa_K3778012 | T7 promoter | 19 |
BBa_K3778013 | RBS (Ribosome-binding site) | 23 |
BBa_K3778014 | 6xHis | 18 |
BBa_K3778015 | Enterokinase cleavage site | 24 |
BBa_K3778016 | CBD (Collagen Binding Domain) | 618 |
BBa_K3778017 | Linker | 24 |
BBa_K3778020 | eGFP | 717 |
BBa_K3778018 | T7 terminator | 48 |
BBa_K3778006 | DPK-060 | 60 |
BBa_K3778022 | Thrombin releasable DPK-060 | 72 |
BBa_K3778007 | D2A21 | 69 |
BBa_K3778023 | Thrombin releasable D2A21 | 81 |
BBa_K3778010 | TAT48-57 | 30 |
BBa_K3778026 | Thrombin releasable TAT48-57 | 42 |
BBa_K1202006 | TAT(Trans-Activator of Transcription) protein | 33 |
BBa_K3778027 | Thrombin releasable TAT | 45 |
BBa_K3778019 | Cathepsin S cleavage site | 12 |
BBa_K3778028 | Cathepsin S-releasable DPK-060 | 72 |
BBa_K3778001 | Thrombin cleavage site for DPK-060 mimic release (LVPRGK) | 18 |
BBa_K3778000 | Thrombin cleavage site (LVPRGS) | 18 |
BBa_K3778002 | Thrombin cleavage site for D2A21 mimic release (LVPRFA) | 18 |
BBa_K3778005 | Thrombin cleavage site for TAT48-57 mimic release (LVPRGR) | 18 |
Composite part
Part name | Description | Length(bp) |
---|---|---|
BBa_K3778021 | T7P-RBS-6xHis-CBD-linker-LVPRGK-eGFP-T7T | 1539 |
BBa_K3778029 | T7P-RBS-6xHis-CBD-linker-LVPRFA-eGFP-T7T | 1539 |
BBa_K3778032 | T7P-RBS-6xHis-CBD-linker-LVPRGR-eGFP-T7T | 1539 |
BBa_K3778033 | T7P-RBS-6xHis-Enterokinase cleavage site-CBD-linker-Thrombin releasable TAT-T7T | 875 |
BBa_K3778034 | T7P-RBS-6xHis-Enterokinase cleavage site-CBD-linker-Thrombin releasable TAT48-57-T7T | 872 |
BBa_K3778035 | T7P-RBS-6xHis-Enterokinase cleavage site-CBD-linker-Thrombin releasable DPK-060-T7T | 902 |
BBa_K3778036 | T7P-RBS-6xHis-Enterokinase cleavage site-CBD-linker-Thrombin releasable D2A21-T7T | 911 |
BBa_K3778039 | Thrombin releasable TAT48-57-6xHis-Cathepsin S releasable DPK-060 | 978 |
BBa_K3778040 | T7P-RBS-6xHis-LVPRGS-TAT48-57-eGFP-T7T | 919 |